Interní Med. 2007; 9(7): 310-313

Sarkoidóza - dosud nepoznaná (2)

prof. MUDr. Vítězslav Kolek DrSc
Klinika plicních nemocí a tuberkulózy, FN a LF UP Olomouc

Dokončení z předchozího čísla.

Published: December 18, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolek V. Sarkoidóza - dosud nepoznaná (2). Interní Med. 2007;9(7):310-313.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Baughman RP, Teirstein AS, Judein MA, et al. Clinical characteristics of patiens in s case control study of sarcoidosis. AJRCCM, 2001; 164: 1885-1892. Go to original source...
    2. Drake WP, Arunkumar R, Silveira L, et al. Immune recognition of Mycobacterial kat G peptides by sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis, 2005; 22: 259.
    3. Drent M, Costabel U. Sarcoidosis. European Respiratory Monograph. ERS, 2005, 341. Go to original source...
    4. Grosser M, Luther T, Fuessel M, et al. Clinical course of sarcoidosis is dependent on HLA-DRB1 allele frequencies, inflammatory markers, and presence of M. tuberculosis DNA fragments. Sarcoidosis Vasc Diffuse Lung Dis, 2005; 22: 66-74.
    5. Grunewald J. Focusing on the human T cell receptor for antigen. Sarcoidosis, 1994; 11: 61-65. Go to PubMed...
    6. Hunninghake GW, Costabel U, Ando M, et al. American Thoracic Society (European Respiratory Society) World Association of Sarcoidosis and Other Granulomatous Disorders: statement on sarcoidosis. Sarcoidosis, 1999; 16: 149-173.
    7. Hutyrova B, Pantelidis P, Drabek J, et al. Interleukin-1 gene polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 2002; 165: p. 148-151. Go to original source... Go to PubMed...
    8. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the moct common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 2005; 22: 33-42.
    9. Kolek V a spol. Sarkoidóza. Známé a neznámé. Avicenum, 1998; 239.
    10. Kolek V, Hutyrova B, Lostakova V. Multicenter epidemiological study on sarcoidosis in Moravia: 1981-2000. Sarcoidosis, Vasculitis and Dif Lung Dis, 2005; 22: 250.
    11. Lenhart K, Kolek V, Bártová A. HLA antigens associated with sarcoidosis. Dis. Markers 1990; 8: 23-29.
    12. Mankiewicz E, Van Walbeck M. Mycobacteriophages. Their role in tuberculosis and sarcoidosis. Arch Environ Hlth, 1962; 5: 122-128. Go to original source... Go to PubMed...
    13. Martinetti M, Tinelli C, Kolek V, et al., ,The Sarcoidosis Map": A joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med, 1995; 152: 557-564. Go to original source... Go to PubMed...
    14. Milman N, Lisby G, Friis S, et al. Prolonged culture for mycobacteria in mediastinal lymph nodes from patients with pulmonary sarcoidosis. A negative study. Sarcoidosis Vasc Diffuse Lung Dis, 2004; 21: 25-28.
    15. Mrazek F, Holla LI, Hutyrova B, et al. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Lofgren' s syndrome in Czech patients with sarcoidosis. Tissue Antigens, 2005; 65: 163-171. Go to original source... Go to PubMed...
    16. Paramonthayan NS, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis. JAMA, 2002; 287: 1301-1307. Go to original source... Go to PubMed...
    17. Petřek M, Drábek J, Kolek V, et al. CC chemokine receptor gene polymorphisms in Czech patients with sarcoidosis. Am J Respir Crit Care Med, 2000; 58: 293-298. Go to original source...
    18. Rossman M, Newman LS, Baughman RP, et al. A double-blinded, randomized, placebo-controlled trial of infliximab in active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, 2005; 22: 265.
    19. Rutherford RM, Staedtler F, Kehren J, et al: Functional genomics and prognosis in sarcoidosis - the critical role of antigen presentation. Sarcoidosis Vasc and Diffuse Lung Dis, 2004; 21: 10-18.
    20. Sabounchi-Schütt F, Mikko M, Eklund A, et al. Serum protein pattern in sarcoidosis analysed by a proteomics approach. Sarcoidosis Vasc. Diffuse Lung Dis, 2004; 21: 182-190. Go to original source... Go to PubMed...
    21. Selroos O, et al. Inhaled budesonide for maintenance treatment of pulmonary sarcoidosis. Sarcoidosis, 1994; 11: 126-131. Go to PubMed...
    22. Yamamoto M, Sharma OP, Hosoda Y. The 1991 descriptive definition of sarcoidosis. Sarcoidosis, 1992; 9: 33-34.
    23. Ziegenhagen MW, Benner UK, Zissel G, et al. Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers. Am J Respir Crit Care Med, 1997; 156: 1586-1592. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.